Sildenafil Potentiates a cGMP-Dependent Pathway to Promote Melanoma Growth

Sandeep Dhayade,
Susanne Kaesler,
Tobias Sinnberg,
Hyazinth Dobrowinski
Stefanie Peters
Ulrike Naumann
He Liu
Robert E. Hunger
Martin Thunemann
Tilo Biedermann
Birgit Schittek
Hans-Uwe Simon
Susanne Feil
Robert Feil

Open Access

DOI: http://dx.doi.org/10.1016/j.celrep.2016.02.028

---

Smith et al., Inhibiting drivers of non-mutational drug-tolerance is a salvage strategy for targeted melanoma therapy. Cancer Cell, 2016. DOI: 10.1016/j.ccell.2016.02.003 

---

J Cell Mol Med. 2016 Mar 1. doi: 10.1111/jcmm.12808. [Epub ahead of print]

Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.

Herwig N^1,2, Belter B¹, Wolf S¹, Haase-Kohn C¹, Pietzsch J

---

CHS BioRxiv

Standard melanoma-associated markers do not identify the MM127 metastatic melanoma cell line

Parvathi Haridas, Jacqui McGovern, Ahishek Kashyap, Sean McElwain, Matthew Simpson

doi: http://dx.doi.org/10.1101/026633

---

Rev Infirm. 2016 Mar;65(219):23-4. doi: 10.1016/j.revinf.2015.12.024.

Choroidal melanoma.

[Article in French]

Desjardins L

---

Lumican Inhibits SNAIL-Induced Melanoma Cell Migration Specifically by Blocking MMP-14 Activity

• Marta Stasiak ,
• Joanna Boncela ,
• Corinne Perreau ,
• Konstantina Karamanou ,
• Aurore Chatron-Colliet ,
• Isabelle Proult ,
• Patrycja Przygodzka ,
• Shukti Chakravarti ,
• François-Xavier Maquart ,
• M. Anna Kowalska ,
• Yanusz Wegrowski ,
• Stéphane Brézillon

• Published: March 1, 2016
• DOI: 10.1371/journal.pone.0150226

---

 

PNAS

doi: 10.1073/pnas.1513801113

Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanoma

1. Yonathan Lissanu Deribe^a,¹,²,
2. Yanxia Shi^a,^b,¹,
3. Kunal Rai^a
4. Luigi Nezi^a,
5. Samir B. Amin^a,
6. Chia-Chin Wu^a,
7. Kadir C. Akdemir^a,
8. Mozhdeh Mahdavi^a,
9. Qian Peng^a,
10. Qing Edward Chang^c,
11. Kirsti Hornigold^d,
12. Stefan T. Arold^e,
13. Heidi C. E. Welch^d,
14. Levi A. Garraway^f,^g, and
15. Lynda Chin^a,^c,²

Author Affiliations

1. Edited by Dennis A. Carson, University of California at San Diego, La Jolla, CA, and approved January 26, 2016 (received for review July 14, 2015)

---

 

BMC Medical Genomics

SOX5 is involved in balanced MITF regulation in human melanoma cells

• Theresa Kordaß, 
• Claudia E. M. Weber, 
• Marcus Oswald, 
• Volker Ast, 
• Mathias Bernhardt, 
• Daniel Novak, 
• Jochen Utikal, 
• Stefan B. Eichmüller^†and 
• Rainer König^†Email author

^{†Contributed equally}

BMC Medical Genomics BMC series – open, inclusive and trusted20169:10

DOI: 10.1186/s12920-016-0170-0

©  Kordaß et al. 2016

Received: 7 August 2015

Accepted: 21 February 2016

Published: 29 February 2016

---

 

Dissecting resistance mechanisms in melanoma combination therapy using a compartment modeling

Eunjung Kim, Alexander Anderson

doi: http://dx.doi.org/10.1101/041855

---

 

Journal of Clinical Pharmacy and Therapeutics

Case Report

You have full text access to this content

Non-HIV-associated Kaposi sarcoma in an immunosuppressed melanoma patient treated with dabrafenib

1. S. Parakh BSc MBChB FRACP

---

Characterization and Inducing Melanoma Cell Apoptosis Activity of Mannosylerythritol Lipids-A Produced from Pseudozyma aphidis

Linlin Fan, Hongji Li,Yongwu Niu,Qihe Chen

• Published: February 1, 2016
• DOI: 10.1371/journal.pone.0148198

---

Melanoma Expressed-CD70 Is Regulated by RhoA and MAPK Pathways without Affecting Vemurafenib Treatment Activity

Christine Pich, Iotefa Teiti ,Guillaume Sarrabayrouse,Franck Gallardo,Rémi Gence,Anne-Françoise Tilkin-Mariamé

• Published: February 1, 2016
• DOI: 10.1371/journal.pone.0148095

---

Immunotherapy. 2016 Feb;8(2):199-209. doi: 10.2217/imt.15.111. Epub 2016 Jan 25.

Immunotherapy for advanced melanoma: future directions.

• Valpione S,Campana LG